NO176019C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-substituert-heksahydrobenz(cd)indoler samt mellomprodukter for disse - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-substituert-heksahydrobenz(cd)indoler samt mellomprodukter for disse

Info

Publication number
NO176019C
NO176019C NO913158A NO913158A NO176019C NO 176019 C NO176019 C NO 176019C NO 913158 A NO913158 A NO 913158A NO 913158 A NO913158 A NO 913158A NO 176019 C NO176019 C NO 176019C
Authority
NO
Norway
Prior art keywords
hexahydrobenz
indoles
intermediates
substituted
preparation
Prior art date
Application number
NO913158A
Other languages
English (en)
Norwegian (no)
Other versions
NO913158L (no
NO913158D0 (no
NO176019B (no
Inventor
Michael Edward Flaugh
Michael John Martinelli
John Mehnert Schaus
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO913158D0 publication Critical patent/NO913158D0/no
Publication of NO913158L publication Critical patent/NO913158L/no
Publication of NO176019B publication Critical patent/NO176019B/no
Publication of NO176019C publication Critical patent/NO176019C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO913158A 1990-08-15 1991-08-13 Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-substituert-heksahydrobenz(cd)indoler samt mellomprodukter for disse NO176019C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56798790A 1990-08-15 1990-08-15
US07/725,177 US5229410A (en) 1990-08-15 1991-07-03 6-substituted-hexahydrobenz[cd]indoles

Publications (4)

Publication Number Publication Date
NO913158D0 NO913158D0 (no) 1991-08-13
NO913158L NO913158L (no) 1992-02-17
NO176019B NO176019B (no) 1994-10-10
NO176019C true NO176019C (no) 1995-01-18

Family

ID=27074631

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913158A NO176019C (no) 1990-08-15 1991-08-13 Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-substituert-heksahydrobenz(cd)indoler samt mellomprodukter for disse

Country Status (17)

Country Link
US (1) US5229410A (pt)
EP (1) EP0471569A1 (pt)
JP (1) JPH04230664A (pt)
KR (1) KR920004346A (pt)
CN (1) CN1058962A (pt)
AU (1) AU648331B2 (pt)
BR (1) BR9103479A (pt)
CS (1) CS249591A3 (pt)
FI (1) FI913834A (pt)
HU (1) HUT59095A (pt)
IE (1) IE912879A1 (pt)
IL (1) IL99149A0 (pt)
MX (1) MX9100644A (pt)
NO (1) NO176019C (pt)
NZ (1) NZ239334A (pt)
PT (1) PT98639A (pt)
YU (1) YU140391A (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
DE69124868T2 (de) * 1990-08-15 1997-07-10 Lilly Co Eli Ring-substituierte 2-Amino-1,2,3,4-tetra-hydronaphthaline, 3-Aminochromane und 3-Aminothiochromane
US5347013A (en) * 1991-03-28 1994-09-13 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
US5633273A (en) * 1991-03-28 1997-05-27 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd] indoles
US5364856A (en) * 1991-03-28 1994-11-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
US5292766A (en) * 1992-03-25 1994-03-08 Eli Lilly And Company Method for improving primary memory and/or learning
US5385928A (en) * 1994-05-18 1995-01-31 Eli Lilly And Company Tetrahydrobenz [CD] indazoles, compositions and use
WO1998046353A1 (en) 1997-04-15 1998-10-22 Massachusetts Institute Of Technology Synthesis and application of vapor grafted porous materials
KR20050043568A (ko) * 2003-11-06 2005-05-11 김상현 두족류 연체동물 포획용 분할형 인공패각

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE517732C (de) * 1927-10-27 1931-02-09 Then Rudolf Faerbekufe mit einem drehbaren, trommelartigen Rahmen fuer die auf aus-wechselbaren Faerbestoecken aufgehaengten Waren, insbesondere Struempfe
BE542760A (pt) * 1954-11-12
US3194811A (en) * 1963-09-05 1965-07-13 Merck & Co Inc Aroyl-benzindolyl acids
BE755270A (fr) * 1969-08-27 1971-02-25 Sandoz Sa Nouveaux derives du benzo(cd)indole, leur preparation et medicaments contenant ces derives
FI206974A (pt) * 1973-07-16 1975-01-17 Sandoz Ag
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
FR2522658A1 (fr) * 1982-03-05 1983-09-09 Roussel Uclaf Application a titre de medicaments de derives du trans 4-amino benz (c,d) indol-5-ol ainsi que de leurs sels, compositions les renfermant, nouveaux derives et leur procede de preparation
DE3346573A1 (de) * 1983-12-23 1985-07-04 Troponwerke GmbH & Co KG, 5000 Köln 1,3,4,5-tetrahydrobenz(c,d)indole, ein verfahren zu ihrer herstellung und ihre verwendung
US4983622A (en) * 1984-02-06 1991-01-08 Eli Lilly And Company 6-substituted-4-dialkylaminotetrahydrobenz(c,d)indoles
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
IL74222A (en) * 1984-02-06 1988-07-31 Lilly Co Eli 6-substituted-4-dialkylamino tetrahydrobenz(c,d)indoles,their preparation and pharmaceutical compositions comprising them
CA1266482A1 (en) * 1984-05-24 1990-03-06 Carl Kaiser 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines
DE3525564A1 (de) * 1985-07-15 1987-02-05 Schering Ag Tricyclische verbindungen mit indolstruktur, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
DE3718892A1 (de) * 1987-06-05 1988-12-22 Bayer Ag Polyhydrobenz(c,d)indol-sulfonamide
US5039820A (en) * 1990-02-26 1991-08-13 Eli Lilly And Company 4-amino-6-iodo-hexahydrobenz(cd)indoles
IL97308A (en) * 1990-02-26 1996-10-31 Lilly Co Eli Xahydrobenz [DC] Induced indoles in position 6, their preparation process and pharmaceutical preparations containing them
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles
IL99500A0 (en) * 1990-09-17 1992-08-18 Agouron Pharma Naphthalene compounds,processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
MX9100644A (es) 1992-04-01
CN1058962A (zh) 1992-02-26
NO913158L (no) 1992-02-17
AU648331B2 (en) 1994-04-21
BR9103479A (pt) 1992-05-12
PT98639A (pt) 1992-06-30
AU8240791A (en) 1992-02-20
NO913158D0 (no) 1991-08-13
NO176019B (no) 1994-10-10
IE912879A1 (en) 1992-02-26
US5229410A (en) 1993-07-20
CS249591A3 (en) 1992-03-18
NZ239334A (en) 1993-05-26
FI913834A (fi) 1992-02-16
JPH04230664A (ja) 1992-08-19
HUT59095A (en) 1992-04-28
FI913834A0 (fi) 1991-08-13
EP0471569A1 (en) 1992-02-19
KR920004346A (ko) 1992-03-27
YU140391A (sh) 1994-06-10
IL99149A0 (en) 1992-07-15
HU912707D0 (en) 1992-01-28

Similar Documents

Publication Publication Date Title
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO175715C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive aminosyrederivater, samt mellomprodukter ved fremstilling av disse
NO177006C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-R2-R4-substituert-3-R3-CO-1-[(C-tilknyttet-N-heteryl)-(Alk)nÅ-1H-indoler, samt mellomprodukt for bruk i denne
MC2313A1 (fr) Inhibiteurs d'enzymes
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
NO179283C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler
NO179448C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
NO175528C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive fenylacetamid-derivater
NO175873C (no) Mikrobiell fremgangsmåte for fremstilling av immunhemmende antibiotika
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
NO914665L (no) Fremgangsmaate til fjerning av trialkylarsiner og sorpsjonsmateriale for utfoerelse av fremgangsmaaten
NO176019C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-substituert-heksahydrobenz(cd)indoler samt mellomprodukter for disse
FI893936A (fi) Menetelmä terapeuttisesti aktiivisten yhdisteiden valmistamiseksi sekä välituotteita
NO176100C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater
NO306817B1 (no) Fremgangsmåte for fremstilling av aluminoksaner
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
NO174774C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner
NO890235L (no) Fremgangsmaate til agglomerering av partikler.
NO304428B1 (no) AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler
NO177673C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N7-substituerte mitomycinderivater
NO175476C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive cykloalkyltiazolderinvater
NO302416B1 (no) Fremgangsmåte for fremstilling av pergolid
NO302421B1 (no) Fremgangsmåte for rensing av faste partikler